Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Steg

Showing results (31-40 of 269) with videos related to

Pageof 27
Sort By:
Advances in Neurology|January 1, 1974
Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neuronsU Ungerstedt, T Ljungberg, G Steg
Journal of the American College of Cardiology|May 1, 1996
Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarctionC Karam, J Golmard, P G Steg
Journal of Electrocardiology|January 1, 1993
Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarctionP G Steg, M Dellborg, M Simoons
Presse Medicale (Paris, France : 1983)|November 5, 2005
[Cardiovascular protection and prevention in patients with cardiac conditions and diabetes]G Charpentier, J Puel, P-G Steg
The American Journal of Cardiology|September 20, 1997
Revascularization of patients with unstable coronary artery disease: the case for early interventionP G Steg, D Himbert, P Seknadji
Cardiovascular Research|August 1, 1996
Perspectives of arterial gene therapy for the prevention of restenosisL J Feldman, O Tahlil, G Steg
Acta Medica Scandinavica|July 1, 1972
Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndromeA K Granerus, G Steg, A Svanborg
Acta Physiologica Scandinavica|June 1, 1971
The influence of the nigro-neostriatal dopamine pathway on spinal motoneuron activityN E Andén, K Larsson, G Steg
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 20, 1999
[Plea for rational use of perfusion methods in the acute stage of myocardial infarct]P G Steg, D Himbert, J M Juliard
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 5, 2001
[Mortality and quality of treatment in myocardial infarction]P G Steg, L J Feldman, P Ravaud
Pageof 27

Showing results (31-40 of 269) with videos related to

Sort By:
Pageof 27
Advances in Neurology|January 1, 1974
Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neuronsU Ungerstedt, T Ljungberg, G Steg
Journal of the American College of Cardiology|May 1, 1996
Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarctionC Karam, J Golmard, P G Steg
Journal of Electrocardiology|January 1, 1993
Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarctionP G Steg, M Dellborg, M Simoons
Presse Medicale (Paris, France : 1983)|November 5, 2005
[Cardiovascular protection and prevention in patients with cardiac conditions and diabetes]G Charpentier, J Puel, P-G Steg
The American Journal of Cardiology|September 20, 1997
Revascularization of patients with unstable coronary artery disease: the case for early interventionP G Steg, D Himbert, P Seknadji
Cardiovascular Research|August 1, 1996
Perspectives of arterial gene therapy for the prevention of restenosisL J Feldman, O Tahlil, G Steg
Acta Medica Scandinavica|July 1, 1972
Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndromeA K Granerus, G Steg, A Svanborg
Acta Physiologica Scandinavica|June 1, 1971
The influence of the nigro-neostriatal dopamine pathway on spinal motoneuron activityN E Andén, K Larsson, G Steg
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 20, 1999
[Plea for rational use of perfusion methods in the acute stage of myocardial infarct]P G Steg, D Himbert, J M Juliard
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 5, 2001
[Mortality and quality of treatment in myocardial infarction]P G Steg, L J Feldman, P Ravaud
Pageof 27